Elalouf J M, Sari D C, Roinel N, de Rouffignac C
Service de Biologie Cellulaire, Centre d'Etudes Nucleaires de Saclay, Gif-sur-Yvette, France.
Proc Natl Acad Sci U S A. 1988 Apr;85(7):2407-11. doi: 10.1073/pnas.85.7.2407.
Previous studies from this laboratory have demonstrated that vasopressin stimulates K, Mg, Ca, Cl, and Na reabsorption by the thick ascending limb of Henle's loop (TALH) of the rat kidney. Micropuncture of superficial nephrons and clearance experiments were performed to determine whether desensitization of the TALH to vasopressin may be demonstrated in vivo and whether such desensitization is specific for the effects of vasopressin (i.e., homologous) or also alters the response to the other hormones acting on the same pool of adenylate cyclase in this nephron segment. Brattleboro rats, with hereditary hypothalamic diabetes insipidus (DI), were given i.m. injections of 1-desamino-8-D-arginine-vasopressin (des-1-amino-[DArg8]VP (herein designated dDAVP); 2 micrograms/day) for 3 days. The effects of maximal physiological doses of arginine-8-vasopressin ([Arg8]VP (herein designated AVP); 20 pg/min per 100 g of body weight) were studied 2 days after the cessation of treatment, when the animals had returned to DI. The K, Mg, Ca, and, to a lesser extent, Cl and Na concentrations in the fluid leaving the TALH of superficial nephrons were higher in dDAVP-treated than in untreated rats given similar amounts of AVP during the experiments. A 50-60% desensitization of the TALH to AVP was still apparent 2 days after stopping the dDAVP injections. Desensitization is homologous, as judged from normal responses to physiological doses of glucagon and calcitonin, two hormones acting on the same cyclase pool as AVP in the rat TALH. The AVP-dependent increase of urine osmolality, however, indicated that its effects on the permeability to water of the collecting duct were scarcely affected in dDAVP-treated rats. It is concluded that (i) AVP induces homologous desensitization in the rat TALH and (ii) the TALH can be markedly desensitized to AVP when the collecting duct response to this hormone is poorly affected or even fully maintained.
本实验室先前的研究表明,血管加压素可刺激大鼠肾脏髓袢升支粗段(TALH)对钾、镁、钙、氯和钠的重吸收。通过对浅表肾单位进行微穿刺和清除实验,以确定TALH对血管加压素的脱敏作用是否可在体内得到证实,以及这种脱敏作用是否对血管加压素的效应具有特异性(即同源性),或者是否也会改变对作用于该肾单位节段同一腺苷酸环化酶池的其他激素的反应。对患有遗传性下丘脑性尿崩症(DI)的布拉特洛维大鼠进行肌肉注射1-去氨基-8-D-精氨酸血管加压素(des-1-氨基-[DArg8]VP(以下简称dDAVP);2微克/天),持续3天。在停止治疗2天后,当动物恢复到尿崩症状态时,研究了最大生理剂量的精氨酸-8-血管加压素([Arg8]VP(以下简称AVP);每100克体重20皮克/分钟)的作用。在实验过程中,给予相似剂量AVP的情况下,接受dDAVP治疗的大鼠浅表肾单位TALH流出液中的钾、镁、钙以及程度较轻的氯和钠浓度高于未治疗的大鼠。停止注射dDAVP 2天后,TALH对AVP的脱敏作用仍明显存在,约为50%-60%。从对生理剂量胰高血糖素和降钙素的正常反应判断,脱敏作用是同源性的,这两种激素与AVP作用于大鼠TALH中的同一环化酶池。然而,AVP依赖的尿渗透压升高表明,在接受dDAVP治疗的大鼠中,其对集合管水通透性的影响几乎未受影响。得出的结论是:(i)AVP在大鼠TALH中诱导同源脱敏;(ii)当集合管对该激素的反应受到轻微影响甚至完全保持时,TALH对AVP可明显脱敏。